Fabien Delacôte

871 citations
15 papers · 626 indexed · h-index 12
Topics
DNA Repair Mechanisms (10 papers)CRISPR and Genetic Engineering (7 papers)PARP inhibition in cancer therapy (4 papers)
Partner nations
FranceSwitzerlandIreland

In The Last Decade

Fabien Delacôte

15 papers receiving 609 citations

Peers

Fabien Delacôte
Comparison fields: 5 of 76
  • Molecular Biology 541
  • Oncology 126
  • Cancer Research 123
  • Plant Science 122
  • Cell Biology 41
Replace Dan Filipescu with:
Dan Filipescu United States
Marco Saponaro United Kingdom
Mihoko Kai United States
Magdalena P. Crossley United States
Jordan Wengrod United States
Yeun Kyu Jang South Korea
Emilia Herrera‐Moyano Spain
Matthew L. Eaton United States
Óscar Reina Spain
Zhihao Ding China
Fabien Delacôte relative to Dan Filipescu United States Dan Filipescu's profile →
Citations per field
00.5×1.5×2.2×
Dan Filipescu · 1×
Citations per year

Countries citing papers authored by Fabien Delacôte

Since Specialization
Citations

This map shows the geographic impact of Fabien Delacôte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabien Delacôte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabien Delacôte more than expected).

Fields of papers citing papers by Fabien Delacôte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabien Delacôte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabien Delacôte. The network helps show where Fabien Delacôte may publish in the future.

Co-authorship network of co-authors of Fabien Delacôte

This figure shows the co-authorship network connecting the top 25 collaborators of Fabien Delacôte. A scholar is included among the top collaborators of Fabien Delacôte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabien Delacôte. Fabien Delacôte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 12
2 64
3 13
4 23
5 4
6 58
7 73
8 38
9 8
10 28
11 2
12 105
13 86
14 75
15 37

About Fabien Delacôte

Fabien Delacôte is a scholar working on Molecular Biology, Cancer Research and Oncology, having authored 15 papers that have together received 626 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (10 papers), CRISPR and Genetic Engineering (7 papers) and PARP inhibition in cancer therapy (4 papers). The work is most often cited by research in Cancer Research (123 citations), Molecular Biology (541 citations) and Oncology (126 citations). Fabien Delacôte has collaborated with scholars based in France, Switzerland and Ireland. Frequent co-authors include Bernard S. López, Fayza Daboussi, Anne Dumay, Pascale Bertrand, Alexandre T. Akhmedov, Antoine Dürrbach, Yannick Saintigny, Fabien Nogué, D. Averbeck and Didier G. Schaefer. Their work appears in journals such as Nucleic Acids Research, PLoS ONE and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026